Diavalkaniko Hospital

Thessaloniki 57001

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Non-Squamous Non-Small Cell Lung Cancer, Small-Cell Lung Cancer

Studies at this site

• A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer — Running, not enrolling
• A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment — Stopped early
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed